The Novel Cholesterol-Lowering Drug SR-12813 Inhibits Cholesterol Synthesis via an Increased Degradation of 3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase
Journal of Biological Chemistry - United States
doi 10.1074/jbc.271.24.14376
Full Text
Open PDFAbstract
Available in full text
Date
June 14, 1996
Authors
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)